These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22020369)

  • 21. A lectin-based monoclonal enzyme immunoassay to distinguish fucosylated and non-fucosylated alpha-fetoprotein molecular variants.
    Suzuki Y; Aoyagi Y; Muramatsu M; Igarashi K; Saito A; Oguro M; Isemura M; Asakura H
    Ann Clin Biochem; 1990 Mar; 27 ( Pt 2)():121-8. PubMed ID: 1691608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of tumor markers for the detection of hepatocellular carcinoma in Yangon General Hospital, Myanmar.
    Taketa K; Okada S; Win N; Hlaing NK; Wind KM
    Acta Med Okayama; 2002 Dec; 56(6):317-20. PubMed ID: 12685861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic performance of tumor markers AFP and PIVKA-II in Chinese hepatocellular carcinoma patients.
    Huang S; Jiang F; Wang Y; Yu Y; Ren S; Wang X; Yin P; Lou J
    Tumour Biol; 2017 Jun; 39(6):1010428317705763. PubMed ID: 28621228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
    Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I
    World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multisite analytical evaluation of the Abbott ARCHITECT cyclosporine assay.
    Wallemacq P; Maine GT; Berg K; Rosiere T; Marquet P; Aimo G; Mengozzi G; Young J; Wonigeit K; Kretschmer R; Wermuth B; Schmid RW
    Ther Drug Monit; 2010 Apr; 32(2):145-51. PubMed ID: 20216110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A combination of α-fetoprotein and des-γ-carboxy prothrombin is superior in detection of hepatocellular carcinoma.
    Ertle JM; Heider D; Wichert M; Keller B; Kueper R; Hilgard P; Gerken G; Schlaak JF
    Digestion; 2013; 87(2):121-31. PubMed ID: 23406785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and application of a fluorescence protein microarray for detecting serum alpha-fetoprotein in patients with hepatocellular carcinoma.
    Zhang A; Yin C; Wang Z; Zhang Y; Zhao Y; Li A; Sun H; Lin D; Li N
    J Int Med Res; 2016 Dec; 44(6):1414-1423. PubMed ID: 27885040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of serum α-fetoprotein-L3% and des-γ carboxyprothrombin markers in cases with misleading hepatocellular carcinoma total α-fetoprotein levels.
    Hadziyannis E; Sialevris K; Georgiou A; Koskinas J
    Oncol Rep; 2013 Feb; 29(2):835-9. PubMed ID: 23174906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of an antibody-lectin enzyme immunoassay for fucosylated α-fetoprotein.
    Korekane H; Hasegawa T; Matsumoto A; Kinoshita N; Miyoshi E; Taniguchi N
    Biochim Biophys Acta; 2012 Sep; 1820(9):1405-11. PubMed ID: 22233759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemiluminescent enzyme immunoassay for alpha-fetoprotein using beta-D-galactosidase as label and 5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside as substrate.
    Arakawa H; Ikegami T; Maeda M; Tsuji A
    J Biolumin Chemilumin; 1993; 8(3):135-9. PubMed ID: 7684183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of analytical performance and comparison of clinical results of the new generation method AccuTnI+3 for the measurement of cardiac troponin I using both patients and quality control plasma samples.
    Storti S; Masotti S; Prontera C; Franzini M; Buzzi P; Casagranda I; Ciofini E; Zucchelli GC; Ndreu R; Passino C; Clerico A
    Clin Chim Acta; 2015 Dec; 451(Pt B):129-34. PubMed ID: 26391123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of high-performance magnetic chemiluminescence enzyme immunoassay for alpha-fetoprotein (AFP) in human serum.
    Wang X; Zhang QY; Li ZJ; Ying XT; Lin JM
    Clin Chim Acta; 2008 Jul; 393(2):90-4. PubMed ID: 18402780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Highly sensitive sandwich enzyme immunoassay for alpha-fetoprotein in human saliva.
    Yio XY; Jiang J; Yin FZ; Ruan KH
    Ann Clin Biochem; 1992 Sep; 29 ( Pt 5)():519-22. PubMed ID: 1280027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of simultaneous determination of alpha-fetoprotein and des-gamma-carboxy prothrombin in hepatocellular carcinoma.
    Nakao A; Taniguchi K; Inoue S; Harada A; Nonami T; Watanabe K; Takagi H
    Semin Surg Oncol; 1996; 12(3):160-3. PubMed ID: 8727604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnetic-bioluminescent-nanoliposomes for ultrasensitive and portable detection of protein biomarkers in blood.
    Liu P; Fang X; Cao H; Gu M; Kong J; Deng A
    Anal Chim Acta; 2018 Dec; 1039():98-107. PubMed ID: 30322558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feasibility of α-fetoprotein as a diagnostic tool for hepatocellular carcinoma in Korea.
    Ahn DG; Kim HJ; Kang H; Lee HW; Bae SH; Lee JH; Paik YH; Lee JS
    Korean J Intern Med; 2016 Jan; 31(1):46-53. PubMed ID: 26767857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein microarray with horseradish peroxidase chemiluminescence for quantification of serum α-fetoprotein.
    Zhao Y; Zhang Y; Lin D; Li K; Yin C; Liu X; Jin B; Sun L; Liu J; Zhang A; Li N
    J Int Med Res; 2015 Oct; 43(5):639-47. PubMed ID: 26198141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Value of alpha 1-fetoprotein (AFP) determination with an ultramicro-ELISA immunoassay in chronic liver diseases with special reference to hepatocellular cancer].
    Reinhardt M; Schulze M; Machnik G; Jorke D; Laske V; Krombholz B; Kappauf G; Schröder S
    Dtsch Z Verdau Stoffwechselkr; 1987; 47(5):230-41. PubMed ID: 2449324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical utility of highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alpha-fetoprotein <20 ng/mL.
    Toyoda H; Kumada T; Tada T; Kaneoka Y; Maeda A; Kanke F; Satomura S
    Cancer Sci; 2011 May; 102(5):1025-31. PubMed ID: 21244578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multi-site analytical evaluation of the Abbott ARCHITECT tacrolimus assay.
    Wallemacq P; Goffinet JS; O'Morchoe S; Rosiere T; Maine GT; Labalette M; Aimo G; Dickson D; Schmidt E; Schwinzer R; Schmid RW
    Ther Drug Monit; 2009 Apr; 31(2):198-204. PubMed ID: 19258928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.